COPENHAGEN (Thomson Financial) - Danisco AS said it will pay competitor Novozymes AS a total of 15.3 mln usd, which includes patent infringement damages of 8.2 mln usd, following the settlement of a patent dispute over the enzyme Spezyme ethyl, which is used in the production of bioethanol.
